Market insight in association with

New liver transplantation technology being used in hospitals

Liver transplantation is the accepted treatment for end-stage-liver failure and is the last option for the patient.

One of the biggest challenges in the transplantation field is the availability of organs, as the number of people that need a transplant far outweighs the number of organs available.

There is therefore a big need for increasing the number of organs that are suitable for transplantation as many patients will die while waiting for an organ to become available.

Currently, organs are stored on ice before being transplanted; however, this can lead to damage of the organ before it is transplanted, making it unusable and further reducing the number of available organs.

The new technology providing a solution

A hospital has become the first in the UK to start using a perfusion machine routinely before liver transplantation.

The perfusion machine maintains the liver in a physiological state, keeping it warm and pumping it with blood, nutrients and, if required, medicine.

This can allow the liver to recover from any damage it may have sustained when being removed from the donor.

A study published in Nature showed that there was 50% lower level of injury in livers that had been kept warm compared with those stored on ice.

Reducing damage will greatly increase the number of organs suitable for transplantation.

Another reason for the lack of available organs is that not everyone who donates their organs will have optimal organs for transplant.

This new perfusion machine means that livers can be tested for function before they are transplanted into a patient so that transplants can be carried out with confidence.

This should further increase the availability of organs for transplant as livers that would have been deemed unsuitable due to uncertainty can now be tested to see if they can be used.

For more insight and data, visit the GlobalData Report Store.

Share this article

Go to article: Home | Track & TraceGo to article: In this issueGo to article: Formacoat Company InsightGo to article: FormacoatGo to article: ContentsGo to article: ElectroCraft Company InsightGo to article: ElectroCraftGo to article: The medical industry briefingGo to article: NewsGo to article: Ginolis Company InsightGo to article: GinolisGo to article: The FDA turns its focus to medical device cybersecurityGo to article: MikronGo to article: How can technology influence the patient-physician relationship?Go to article: Micro Systems TechnologiesGo to article: NeuroLife: a brain implant that may circumvent paralysisGo to article: BISAGo to article: Is artificial intelligence the future of drug discovery?Go to article: What can AI bring to healthcare and medical research?Go to article: Telemed Company InsightGo to article: TelemedGo to article: Learning together: tetraplegic humans work with machines to win raceGo to article: New liver transplantation technology being used in hospitalsGo to article: MPS Microsystems Company InsightGo to article: MPS MicrosystemsGo to article: EU Medical Device Regulation: manufacturers’ responsibilities Go to article: NSFGo to article: Tech watch: machine learning in healthcareGo to article: ARPAGo to article: One small step for man: Meet HAL, the Japanese cyborg medical exoskeleton helping US patients walk againGo to article: AerotechGo to article: Optimising the care pathway: A vision of connected healthcare deliveryGo to article: Next issueGo to article: Events